Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Diego Martinez vasquez"'
Autor:
Maria F. Toniolo, Tham M. Yao, Vincent Ricchiuti, Gordon H. Williams, Luminita H. Pojoga, Eveline Oestreicher, Christine Guo, Nathalie Lapointe, Diego Martinez-Vasquez, Gail K. Adler, Taisuke Kikuchi, Gonzalo P. Mendez
Publikováno v:
Endocrinology. 147:5363-5373
To determine whether mineralocorticoid receptor (MR) activation plays a role in diabetic renal injury and whether this role differs in types 1 and 2 diabetes mellitus, we examined the effect of a MR antagonist on renal injury in rodent models of type
Autor:
Gail K. Adler, James R. Stone, Diego Martinez-Vasquez, Weranuj Roubsanthisuk, Larus Jonasson, Eveline Oestreicher, Koji Mukasa
Publikováno v:
Circulation. 108:2517-2523
Background— Angiotensin II (Ang II) increases levels of aldosterone and plasminogen activator inhibitor-1 (PAI-1). Both aldosterone and PAI-1 seem to promote cardiovascular (CV) injury. Our objective was to determine the roles of PAI-1 and aldoster
Autor:
Diego Martinez-Vasquez, Weranuj Roubsanthisuk, Gail K. Adler, L. Jonasson, D. Burr, Christine Guo, Ellen W. Seely, Tham M. Yao, Eveline Oestreicher, T. Kikuchi, Sonia R. Mayoral, Vincent Ricchiuti
Publikováno v:
Kidney international. 70(10)
Prospective, placebo-controlled clinical trials suggest that estrogen may have adverse effects on the vascular system in women. The goal of this study was to determine if 17beta-estradiol (E2) would have adverse effects on the renovasculature in a ra
Publikováno v:
Hypertension. 36:723-723
P165 Aldosterone through its interaction with the mineralocorticoid receptor (MR) plays a critical role in the development of hypertension and cardiovascular injury (CVI). Normally, MR is protected by 11β-hydroxysteroid dehydrogenase (11β-HSD) whic